SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-12-215311
Filing Date
2012-05-07
Accepted
2012-05-07 16:59:51
Documents
10
Period of Report
2012-03-31
Filing Date Changed
2012-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d342222d10q.htm 10-Q 455757
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 d342222dex311.htm EX-31.1 10396
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 d342222dex312.htm EX-31.2 10408
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER d342222dex32.htm EX-32 7630
10 GRAPHIC g342222tx_pg019.jpg GRAPHIC 64630
  Complete submission text file 0001193125-12-215311.txt   1652863

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT halo-20120331.xml EX-101.INS 153520
6 XBRL TAXONOMY EXTENSION SCHEMA halo-20120331.xsd EX-101.SCH 8716
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE halo-20120331_cal.xml EX-101.CAL 23541
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE halo-20120331_lab.xml EX-101.LAB 86068
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE halo-20120331_pre.xml EX-101.PRE 54192
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 12818547
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1